Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NOTUM | Q6P988 | 13/20 | 0.42 |
| ▸ | CDC7 | O00311 | 1/20 | 0.39 |
| ▸ | DBF4 | Q9UBU7 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 2/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.37 |
| ▸ | HPGD | P15428 | 1/20 | 0.37 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.37 |
| ▸ | TSHR | P16473 | 1/20 | 0.36 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.35 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.35 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.35 |
| ▸ | TLR8 | Q9NR97 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13801153 | 0.83 | NOTUM (0.55) | NOTUMCDC7DBF4MAPTALDH1A1 | |
| SCHEMBL12906161 | 0.72 | NOTUM (0.59) | NOTUMMAPTALDH1A1HPGDMAPK1 | |
| SCHEMBL5067577 | 0.72 | ALDH1A1 (0.36) | NOTUMMAPTALDH1A1 | |
| SCHEMBL4766812 | 0.70 | NOTUM (0.42) | NOTUMMAPTALDH1A1TSHRTLR8 | |
| SCHEMBL25144924 | 0.68 | NOTUM (0.43) | NOTUMCDC7DBF4MAPTALDH1A1 | |
| SCHEMBL21547878 | 0.68 | NOTUM (0.43) | NOTUMCDC7DBF4MAPTALDH1A1 | |
| SCHEMBL21539002 | 0.65 | NOTUM (0.44) | NOTUMCDC7DBF4MAPTALDH1A1 | |
| SCHEMBL21366093 | 0.65 | NOTUM (0.40) | NOTUMCDC7DBF4MAPTALDH1A1 | |
| SCHEMBL21366186 | 0.65 | NOTUM (0.36) | NOTUMCDC7DBF4MAPTALDH1A1 | |
| SCHEMBL21547804 | 0.65 | NOTUM (0.44) | NOTUMCDC7DBF4MAPTALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090156827-A1 | MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS AND ORGANIC ELECTROLUMINESCENT ELEMENT | TOYO INK MFG. CO., LTD. (JP) | 2009-06-18 | — | — | US | disclosed |
| US-20090156827-A1 | MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS AND ORGANIC ELECTROLUMINESCENT ELEMENT | TOYO INK MFG. CO., LTD. (JP) | 2009-06-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090156827-A1 | MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS AND ORGANIC ELECTROLUMINESCENT ELEMENT | ELP1, ELAVL1, ELF3 | NOTUM 3406/4885CDC7 4772/4885DBF4 2647/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.